The results showed that the use of Ang-II stimulating AHMs was associated with a 13% decrease in the risk of all-cause dementia compared to Ang-II inhibiting AHMs (HR = 0.87; 95% CI = 0.82–0.93, p < 0.01) (Fig. 2). This evidence concerns the gene AGT and dementia.